• Computers and Concrete
• /
• 제18권2호
• /
• pp.155-163
• /
• 2016

This paper, proposes 20 models for predicting compressive strength of recycled aggregate concrete (RAC) containing silica fume by using gene expression programming (GEP). To construct the models, experimental data of 228 specimens produced from 61 different mixtures were collected from the literature. 80% of data sets were used in the training phase and the remained 20% in testing phase. Input variables were arranged in a format of seven input parameters including age of the specimen, cement content, water content, natural aggregates content, recycled aggregates content, silica fume content and amount of superplasticizer. The training and testing showed the models have good conformity with experimental results for predicting the compressive strength of recycled aggregate concrete containing silica fume.

• Computers and Concrete
• /
• 제19권6호
• /
• pp.717-724
• /
• 2017

In this paper, four formulas are proposed via gene expression programming (GEP)-based models and regression analysis (RA) to predict the flexural strength ($f_s$) values of mortars containing different mineral admixtures that are ground granulated blast-furnace slag (GGBFS), silica fume (SF) and fly ash (FA) at different ages. Three formulas obtained from the GEP-I, GEP-II and GEP-III models are constituted to predict the $f_s$ values from the age of specimen, water-binder ratio and compressive strength. Besides, one formula obtained from the RA is constituted to predict the $f_s$ values from the compressive strength. To achieve these formulas in the GEP and RA models, 972 data of the experimental studies presented with mortar mixtures were gathered from the literatures. 734 data of the experimental studies are divided without pre-planned for these formulas achieved from the training and testing sets of GEP and RA models. Beside, these formulas are validated with 238 data of experimental studies un-employed in training and testing sets. The $f_s$ results obtained from the training, testing and validation sets of these formulas are compared with the results obtained from the experimental studies and the formulas given in the literature for concrete. These comparisons show that the results of the formulas obtained from the GEP and RA models appear to well compatible with the experimental results and find to be very credible according to the results of other formulas.

• Journal of Medicine and Life Science
• /
• 제20권3호
• /
• pp.107-114
• /
• 2023

Epidemiological control of coronavirus disease 2019 (COVID-19) is needed to estimate the infection period of confirmed cases and identify potential cases. The present study, targeting confirmed cases for which the time of COVID-19 symptom onset was disclosed, aimed to investigate the relationship between intervals (day) from symptom onset to testing the cycle threshold (CT) values of real-time reverse transcription-polymerase chain reaction. Of the COVID-19 confirmed cases, those for which the date of suspected symptom onset in the epidemiological investigation was specifically disclosed were included in this study. Interval was defined as the number of days from symptom onset (as disclosed by the patient) to specimen collection for testing. A locally weighted regression smoothing (LOWESS) curve was applied, with intervals as explanatory variables and CT values (CTR for RdRp gene and CTE for E gene) as outcome variables. After finding its non-linear relationship, a polynomial regression model was applied to estimate the 95% confidence interval values of CTR and CTE by interval. The application of LOWESS in 331 patients identified a U-shaped curve relationship between the CTR and CTE values according to the number of interval days, and both CTR and CTE satisfied the quadratic model for interval days. Active application of these results to epidemiological investigations would minimize the chance of failing to identify individuals who are in contact with COVID-19 confirmed cases, thereby reducing the potential transmission of the virus to local communities.

• Genomics & Informatics
• /
• 제14권4호
• /
• pp.187-195
• /
• 2016

In genetic association studies with high-dimensional genomic data, multiple group testing procedures are often required in order to identify disease/trait-related genes or genetic regions, where multiple genetic sites or variants are located within the same gene or genetic region. However, statistical testing procedures based on an individual test suffer from multiple testing issues such as the control of family-wise error rate and dependent tests. Moreover, detecting only a few of genes associated with a phenotype outcome among tens of thousands of genes is of main interest in genetic association studies. In this reason regularization procedures, where a phenotype outcome regresses on all genomic markers and then regression coefficients are estimated based on a penalized likelihood, have been considered as a good alternative approach to analysis of high-dimensional genomic data. But, selection performance of regularization procedures has been rarely compared with that of statistical group testing procedures. In this article, we performed extensive simulation studies where commonly used group testing procedures such as principal component analysis, Hotelling's $T^2$ test, and permutation test are compared with group lasso (least absolute selection and shrinkage operator) in terms of true positive selection. Also, we applied all methods considered in simulation studies to identify genes associated with ovarian cancer from over 20,000 genetic sites generated from Illumina Infinium HumanMethylation27K Beadchip. We found a big discrepancy of selected genes between multiple group testing procedures and group lasso.

• 한국발생생물학회지:발생과생식
• /
• 제25권2호
• /
• pp.113-121
• /
• 2021

This article aims to introduce German discussion on the approval of the non-invasive prenatal diagnosis (NIPD), which started with the development of PrenaTest^® by LifeCodexx AG. The discussion started with the concern that the non-invasive nature of NIPD, such as PrenaTest^®, may rapidly expand the use and scope of similar tests, thus leading to a new era of eugenics. Based on this concern, the need for clear clinical guidelines on specific indications for NIPD has been suggested. Along the same line, it was discussed whether PrenaTest^® is against the Basic Law prohibiting discrimination on grounds of disability and whether the test is outside the scope of the purpose of gene testing limited by Genetic Diagnosis Act. Through such discussion, the Federal Ministry of Health of Germany established the preconditions for inclusion of NIPD in the German public health insurance system. For this, the German motherhood guideline was amended and the information for the insured persons provided to pregnant women was included in the amended guideline. Such discussion made in Germany provides insight on which points should be considered when various gene testings are accepted in Korea, in which genetic communication has not been systematized yet. In particular, German counseling system for pregnant women will provide valuable insights for Korea where the direction for regulations on abortion has not been established even after the ruling by the Constitutional Court that charges for abortion are against the constitution.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권3호
• /
• pp.1539-1546
• /
• 2016

Specific patterns of the hereditary breast and ovarian cancer (HBOC) syndrome are related to mutations in the BRCA1 gene. One hundred unrelated breast cancer patients were interviewed to obtain clinical symptoms and signs, pedigree and familial history of HBOC syndrome related cancer. Subsequently, data were calculated using the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) risk prediction model. Patients with high score of BOADICEA were offered genetic testing. Eleven patients with high score of BOADICEA, 2 patients with low score of BOADICEA, 2 patient's family members and 15 controls underwent BRCA1 genetic testing. Mutation screening using PCR-HRM was carried out in 22 exons (41 amplicons) of BRCA1 gene. Sanger sequencing was subjected in all samples with aberrant graph. This study identified 10 variants in the BRCA1 gene, consisting of 6 missense mutations (c.1480C>A, c.2612C>T, c.2566T>C, c.3113A>G, c.3548 A>G, c.4837 A>G), 3 synonymous mutations (c.2082 C>T, c.2311 T>C and c.4308T>C) and one intronic mutation (c.134+35 G>T). All variants tend to be polymorphisms and unclassified variants. However, no known pathogenic mutations were found.

• Journal of the Korean Data and Information Science Society
• /
• 제25권6호
• /
• pp.1385-1395
• /
• 2014

가축의 경제적인 특성은 환경적인 요인과 유전적인 요인의 영향을 받으며, 또한 하나의 유전자가 아닌 여러 유전자의 상호작용의 영향을 받는다고 알려져 있다. 본 논문에서는 선형회귀모형을 활용하여 환경적인 요인을 보정한 자료로 한우의 맛과 육질에 영향을 준다고 밝혀진 지방산합성효소의 단일염기다형성 5개를 이용해 한우의 경제 형질에 영향을 미치는 우수 유전자 조합을 선별하고 우수 유전자형을 밝힌다. 이를 위해 데이터마이닝 기법인 인공신경망, 로지스틱 회귀모형, C5.0, CART 기법을 이용하였다. 공정한 모형 평가를 위해 전체 데이터를 훈련용 데이터 (60%)와 검증용 데이터 (40%)로 나누었고, 훈련용 데이터에서 설정된 모형을 검증용 데이터에 적용시켜 정확도를 비교하였다. 그 결과 C5.0이 최적 모형으로 선정되었으며, C5.0의 의사결정나무를 통해 우수 유전자 조합을 선별하였다.

• Journal of the Korean Data and Information Science Society
• /
• 제25권5호
• /
• pp.971-986
• /
• 2014

동시에 여러 개의 가설검정 수행시 귀무가설이 참일 경우 귀무가설을 기각할 확률이 커지는 문제가 발생한다. 이러한 다중검정 문제 해결을 위해 여러 연구에서는 가설검정시 필요한 집단별 오류율(FWER; family-wise error rate), 위발견율 (FDR; false discovery rate) 또는 위비발견율 (FNR; false nondiscovery rate) 과 통계량을 고려하여 검정력을 높이고자 하였다. 본 연구에서는 T 통계량, 수정된 T 통계량, 그리고 LPE (local pooled error) 통계량 기반 P값을 이용한 Bonferroni (1960) 방법, Holm (1979) 방법, Benjamini와 Hochberg (1995) 방법과 Benjamini와 Yekutieli (2001) 방법 그리고 Z 통계량 기반 Sun과 Cai (2007) 방법을 고찰하고 모의실험을 통해 다중검정 능력을 비교하였다. 또한 실제 데이터로 애기장대 유전자 발현 데이터에 대해 여러 가지 다중검정법을 통해 유의한 유전자들을 선별하였다.

• Journal of Veterinary Science
• /
• 제22권6호
• /
• pp.76.1-76.15
• /
• 2021

Background: The development of a vaccine for Jembrana disease is needed to prevent losses in Indonesia's Bali cattle industry. A DNA vaccine model (pEGFP-C1-tat) that requires a functional delivery system will be developed. Polylactic-co-glycolic acid (PLGA) may have potential as a delivery system for the vaccine model. Objectives: This study aims to evaluate the in vitro potential of PLGA as a delivery system for pEGFP-C1-tat. Methods: Consensus and codon optimization for the tat gene was completed using a bioinformatic method, and the product was inserted into a pEGFP-C1 vector. Cloning of the pEGFP-C1-tat was successfully performed, and polymerase chain reaction (PCR) and restriction analysis confirmed DNA isolation. PLGA-pEGFP-C1-tat solutions were prepared for encapsulated formulation testing, physicochemical characterization, stability testing with DNase I, and cytotoxicity testing. The PLGA-pEGFP-C1-tat solutions were transfected in HeLa cells, and gene expression was observed by fluorescent microscopy and real-time PCR. Results: The successful acquisition of transformant bacteria was confirmed by PCR. The PLGA:DNA:polyvinyl alcohol ratio formulation with optimal encapsulation was 4%:0.5%:2%, physicochemical characterization of PLGA revealed a polydispersity index value of 0.246, a particle size of 925 nm, and a zeta potential value of -2.31 mV. PLGA succeeded in protecting pEGFP-C1-tat from enzymatic degradation, and the percentage viability from the cytotoxicity test of PLGA-pEGFP-C1-tat was 98.03%. The PLGA-pEGFP-C1-tat demonstrated luminescence of the EGFP-tat fusion protein and mRNA transcription was detected. Conclusions: PLGA has good potential as a delivery system for pEGFP-C1-tat.

• Clinical and Experimental Pediatrics
• /
• 제53권7호
• /
• pp.774-777
• /
• 2010

Pfeiffer syndrome is a rare autosomal dominant disorder characterized by coronal craniosynostosis, brachycephaly, mid-facial hypoplasia, and broad and deviated thumbs and great toes. Pfeiffer syndrome occurs in approximately 1:100,000 live births. Clinical manifestations and molecular genetic testing are important to confirm the diagnosis. Mutations of the fibroblast growth factor receptor 1 ($FGFR1$) gene or $FGFR2$ gene can cause Pfeiffer syndrome. Here, we describe a case of Pfeiffer syndrome with a novel c833_834GC>TG mutation (encoding Cys278Leu) in the $FGFR2$ gene associated with a coccygeal anomaly, which is rare in Pfeiffer syndrome.